{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:01:10Z","timestamp":1759334470888,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.imbio.2007.01.001","type":"journal-article","created":{"date-parts":[[2007,2,3]],"date-time":"2007-02-03T02:46:33Z","timestamp":1170470793000},"page":"193-199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Anti-\u03b22-glycoprotein I antibodies of IgM class are linked to thrombotic disorders in young women without autoimmune disease"],"prefix":"10.1016","volume":"212","author":[{"given":"Barbara","family":"Salobir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi\u0161o","family":"\u0160abovi\u010d","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maja","family":"Hojnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sa\u0161a","family":"\u010cu\u010dnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanja","family":"Kveder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2007.01.001_bib1","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/rheumatology\/keh241","article-title":"Comparison of different kits in the detection of autoantibodies to cardiolipin and \u03b22-glycoprotein I: comment on the article by Audrain et al","volume":"43","author":"Ambro\u017ei\u010d","year":"2004","journal-title":"Rheumatology"},{"key":"10.1016\/j.imbio.2007.01.001_bib2","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/rheumatology\/35.12.1239","article-title":"Specificity of ELISA for antibody to \u03b22-glycoprotein I in patients with antiphospholipid syndrome","volume":"35","author":"Amengual","year":"1996","journal-title":"Br. J. Rheumatol."},{"key":"10.1016\/j.imbio.2007.01.001_bib3","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1046\/j.1538-7836.2003.00125.x","article-title":"Current status and implications of autoimmune antiphospholipid antibodies in relation to thrombotic disease","volume":"1","author":"Arnout","year":"2003","journal-title":"J. Thromb. Haemostas."},{"key":"10.1016\/j.imbio.2007.01.001_bib4","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/rheumatology\/40.5.565","article-title":"Anticardiolipin and anti-\u03b2-glycoprotein 1 antibodies in sera of 61 apparently healthy children at regular preventive visits","volume":"40","author":"Av\u010din","year":"2001","journal-title":"Rheumatology"},{"key":"10.1016\/j.imbio.2007.01.001_bib5","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/0140-6736(91)93206-O","article-title":"Classification and natural history of clinically identifiable subtypes of cerebral infarction","volume":"337","author":"Bamford","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.imbio.2007.01.001_bib6","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1161\/01.STR.32.8.1701","article-title":"Beta(2)-glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: the honolulu heart program","volume":"32","author":"Brey","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.imbio.2007.01.001_bib7","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/jcp.11.5.403","article-title":"The effect of citrate on euglobulin methods of estimating fibrinolytic activity","volume":"11","author":"Buckell","year":"1958","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.imbio.2007.01.001_bib8","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1515\/CCLM.2000.111","article-title":"Anti-\u03b22-glycoprotein I ELISA: methodology, determination of cut-off values in 434 healthy Caucasians and evaluation of monoclonal antibodies as possible international standards","volume":"38","author":"\u010cu\u010dnik","year":"2000","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.imbio.2007.01.001_bib9","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1073\/pnas.90.3.1004","article-title":"Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C","volume":"90","author":"Dahlback","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.imbio.2007.01.001_bib10","first-page":"675","article-title":"High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome","volume":"25","author":"Fanopoulos","year":"1998","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.imbio.2007.01.001_bib11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/08916939908994766","article-title":"High prevalence of anti-beta2 glycoprotein I antibodies in patients with ischemic heart disease","volume":"30","author":"Farsi","year":"1999","journal-title":"Autoimmunity"},{"key":"10.1016\/j.imbio.2007.01.001_bib12","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0022-2143(99)90101-4","article-title":"Occurrence of anti-prothrombin and anti-beta2-glycoprotein I antibodies in patients with history of thrombosis","volume":"134","author":"Forastiero","year":"1999","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.imbio.2007.01.001_bib13","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/sj.thj.6200206","article-title":"Antiphospholipid antibodies and thrombosis: strength of association","volume":"4","author":"Galli","year":"2003","journal-title":"Hematol. J."},{"key":"10.1016\/j.imbio.2007.01.001_bib14","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1055\/s-0037-1614164","article-title":"Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests","volume":"84","author":"Galli","year":"2000","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.imbio.2007.01.001_bib15","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1177\/096120339900800607","article-title":"Induction of antiphospholipid antibodies by immunization with synthetic viral and bacterial peptides","volume":"8","author":"Gharavi","year":"1999","journal-title":"Lupus"},{"key":"10.1016\/j.imbio.2007.01.001_bib16","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/S0140-6736(98)10362-8","article-title":"Antiphospholipid antibodies and thrombosis","volume":"353","author":"Greaves","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.imbio.2007.01.001_bib17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/08916939908994054","article-title":"Anti-beta 2-glycoprotein I antibody isotype and IgG subclass in antiphospholipid syndrome patients","volume":"31","author":"Guerin","year":"1999","journal-title":"Autoimmunity"},{"key":"10.1016\/j.imbio.2007.01.001_bib18","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000206456","article-title":"Determination of the thrombin time","volume":"24","author":"Hougie","year":"1960","journal-title":"Acta Haematol."},{"key":"10.1016\/j.imbio.2007.01.001_bib19","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1177\/096120339800700201","article-title":"Hughes\u2019 syndrome: the antiphospholipid syndrome. A historical view","volume":"7","author":"Hughes","year":"1998","journal-title":"Lupus"},{"key":"10.1016\/j.imbio.2007.01.001_bib20","first-page":"269","article-title":"Speculation on APS in the coming millennium","volume":"15","author":"Hughes","year":"2000","journal-title":"Lupus"},{"key":"10.1016\/j.imbio.2007.01.001_bib21","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/rheumatology\/36.12.1247","article-title":"\u03b22-glycoprotein I and anti-\u03b22-glycoprotein I antibodies: where are we now?","volume":"36","author":"Inanc","year":"1997","journal-title":"Br. J. Rheumatol."},{"key":"10.1016\/j.imbio.2007.01.001_bib22","unstructured":"Janeway, C.A., Travers, P., Walport, M., Shlomchik, M.J., 2001. The humoral immune response. In: Immunobiology. The Immune System in Health and Disease, 5th ed. Garland Churchill Livingstone, New York, pp. 341\u2013380."},{"key":"10.1016\/j.imbio.2007.01.001_bib23","series-title":"Contemporary Endocrinology: Insulin Resistance","first-page":"317","article-title":"PAI-1, obesity and insulin resistance","author":"Juhan-Vague","year":"1999"},{"key":"10.1016\/j.imbio.2007.01.001_bib24","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1046\/j.1365-2249.1999.01007.x","article-title":"Isotype distribution and clinical relevance of anti-beta2-glycoprotein I (beta2-GPI) antibodies: importance of IgA isotype","volume":"117","author":"Lakos","year":"1999","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.imbio.2007.01.001_bib25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/00365517209102748","article-title":"Electroimmunoassay","volume":"29","author":"Laurell","year":"1972","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.imbio.2007.01.001_bib26","first-page":"520","article-title":"Isotypes of anti-beta2-glycoprotein I antibodies: association with thrombosis in patients with systemic lupus erythematosus","volume":"28","author":"Lee","year":"2001","journal-title":"J. Rheumatol."},{"year":"1976","series-title":"Results of WHO International Collaborative Study","key":"10.1016\/j.imbio.2007.01.001_bib27"},{"key":"10.1016\/j.imbio.2007.01.001_bib28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1006\/jaut.2000.0409","article-title":"Epidemiology of antiphospholipid antibody syndrome","volume":"15","author":"Petri","year":"2000","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.imbio.2007.01.001_bib29","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1055\/s-0037-1613293","article-title":"Anti-beta2-glycoprotein I and anti-prothrombin antibodies in antiphospholipid-negative patients with thrombosis: a case control study","volume":"88","author":"Previtali","year":"2002","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.imbio.2007.01.001_bib30","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/00000441-193510000-00009","article-title":"A study of the coagulation defect in hemophilia and jaundice","volume":"190","author":"Quick","year":"1935","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.imbio.2007.01.001_bib31","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1160\/TH05-02-0081","article-title":"European forum on antiphospholipid antibodies standardisation group. Variability of anti-beta2-glycoprotein I antibodies measurements by commercial assays","volume":"94","author":"Reber","year":"2005","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.imbio.2007.01.001_bib32","first-page":"2131","article-title":"Antibodies to beta2-glycoprotein I: a potential marker for clinical features of antiphospholipid antibody syndrome in patients with systemic lupus erythematosus","volume":"25","author":"Sanfilippo","year":"1998","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.imbio.2007.01.001_bib33","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000047411","article-title":"Autoantibodies to cardiolipin and \u03b22-glycoprotein I in coronary artery disease patients with and without hypertension","volume":"97","author":"Sherer","year":"2002","journal-title":"Cardiology"},{"key":"10.1016\/j.imbio.2007.01.001_bib34","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0049-3848(91)90230-T","article-title":"Prevalence of antiphospholipid antibodies in deep vein thrombosis and their relationship to blood coagulation and fibrinolysis","volume":"63","author":"Stegnar","year":"1991","journal-title":"Thromb. Res."},{"key":"10.1016\/j.imbio.2007.01.001_bib35","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/art.1780390905","article-title":"Antibodies to \u03b22-glycoprotein I and clinical manifestations in patients with systemic lupus erythemathosus","volume":"39","author":"Tsutsumi","year":"1996","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imbio.2007.01.001_bib36","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/1529-0131(199707)40:7<1366::AID-ART26>3.0.CO;2-5","article-title":"Antibodies to \u03b22-glycoprotein I and clinical manifestations in patients with systemic lupus erythemathosus: reply","volume":"40","author":"Tsutsumi","year":"1997","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imbio.2007.01.001_bib37","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1053\/euhj.1998.1243","article-title":"Prevention of coronary heart disease in clinical practice. Recommendations of the second joint task force of European and other societies on coronary prevention","volume":"19","author":"Wood","year":"1998","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.imbio.2007.01.001_bib38","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/0895-4356(95)00516-1","article-title":"A multinational case-control study of cardiovascular disease and steroid hormone contraceptives: description and validation of methods","volume":"48","year":"1995","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.imbio.2007.01.001_bib39","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0049-3848(99)00105-X","article-title":"Anti-beta2-glycoprotein I antibodies in patients with acute venous thromboembolism: prevalence and association with recurrent thromboembolism","volume":"96","author":"Zanon","year":"1999","journal-title":"Thromb. Res."}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298507000022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298507000022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:21:48Z","timestamp":1759249308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298507000022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0171298507000022"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2007.01.001","relation":{},"ISSN":["0171-2985"],"issn-type":[{"type":"print","value":"0171-2985"}],"subject":[],"published":{"date-parts":[[2007,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-\u03b22-glycoprotein I antibodies of IgM class are linked to thrombotic disorders in young women without autoimmune disease","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2007.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}